Home

Csarnok Óceánia hardver sakre sclc elviselni kulacs Halálos

Cancers | Free Full-Text | Transcriptional Profiling Reveals Mesenchymal  Subtypes of Small Cell Lung Cancer with Activation of the  Epithelial-to-Mesenchymal Transition and Worse Clinical Outcomes
Cancers | Free Full-Text | Transcriptional Profiling Reveals Mesenchymal Subtypes of Small Cell Lung Cancer with Activation of the Epithelial-to-Mesenchymal Transition and Worse Clinical Outcomes

PI3K/AKT/mTOR pathway, hypoxia, and glucose metabolism: Potential targets  to overcome radioresistance in small cell lung cancer | Cancer Pathogenesis  and Therapy
PI3K/AKT/mTOR pathway, hypoxia, and glucose metabolism: Potential targets to overcome radioresistance in small cell lung cancer | Cancer Pathogenesis and Therapy

Cancers | Free Full-Text | Emerging Biomarkers and the Changing Landscape  of Small Cell Lung Cancer
Cancers | Free Full-Text | Emerging Biomarkers and the Changing Landscape of Small Cell Lung Cancer

RICTOR amplification identifies a subgroup in small cell lung cancer and  predicts response to drugs targeting mTOR | Oncotarget
RICTOR amplification identifies a subgroup in small cell lung cancer and predicts response to drugs targeting mTOR | Oncotarget

Simultaneously targeting DNA damage repair pathway and mTORC1/2 results in small  cell lung cancer growth arrest via ER stress-induced apoptosis
Simultaneously targeting DNA damage repair pathway and mTORC1/2 results in small cell lung cancer growth arrest via ER stress-induced apoptosis

A multiplexed in vivo approach to identify driver genes in small cell lung  cancer | bioRxiv
A multiplexed in vivo approach to identify driver genes in small cell lung cancer | bioRxiv

Genomic Profiling of Circulating Tumor DNA from Patients with  Extensive-Stage Small Cell Lung Cancer Identifies Potentially Actionable  Alterations
Genomic Profiling of Circulating Tumor DNA from Patients with Extensive-Stage Small Cell Lung Cancer Identifies Potentially Actionable Alterations

Nneha Sakre PhD - Biosafety Specialist II - Stanford University | LinkedIn
Nneha Sakre PhD - Biosafety Specialist II - Stanford University | LinkedIn

MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by  Reprogramming Neuroendocrine Fate - ScienceDirect
MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate - ScienceDirect

Molecular profiles of small cell lung cancer subtypes: Therapeutic  implications: Molecular Therapy - Oncolytics
Molecular profiles of small cell lung cancer subtypes: Therapeutic implications: Molecular Therapy - Oncolytics

YAP1 promotes multidrug resistance of small cell lung cancer by  CD74‐related signaling pathways - Song - 2020 - Cancer Medicine - Wiley  Online Library
YAP1 promotes multidrug resistance of small cell lung cancer by CD74‐related signaling pathways - Song - 2020 - Cancer Medicine - Wiley Online Library

FOXM1 is required for small cell lung cancer tumorigenesis and associated  with poor clinical prognosis | Oncogene
FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis | Oncogene

Cancers | Free Full-Text | Emerging Biomarkers and the Changing Landscape  of Small Cell Lung Cancer
Cancers | Free Full-Text | Emerging Biomarkers and the Changing Landscape of Small Cell Lung Cancer

Molecular Subtypes of Primary SCLC Tumors and Their Associations With  Neuroendocrine and Therapeutic Markers - ScienceDirect
Molecular Subtypes of Primary SCLC Tumors and Their Associations With Neuroendocrine and Therapeutic Markers - ScienceDirect

A multiplexed in vivo approach to identify driver genes in small cell lung  cancer - ScienceDirect
A multiplexed in vivo approach to identify driver genes in small cell lung cancer - ScienceDirect

YAP1 promotes multidrug resistance of small cell lung cancer by  CD74‐related signaling pathways - Song - 2020 - Cancer Medicine - Wiley  Online Library
YAP1 promotes multidrug resistance of small cell lung cancer by CD74‐related signaling pathways - Song - 2020 - Cancer Medicine - Wiley Online Library

YAP drives fate conversion and chemoresistance of small cell lung cancer |  Science Advances
YAP drives fate conversion and chemoresistance of small cell lung cancer | Science Advances

SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive  Immunohistochemical and Histopathologic Characterization - ScienceDirect
SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization - ScienceDirect

Multivalent state transitions shape the intratumoral composition of small  cell lung carcinoma | Science Advances
Multivalent state transitions shape the intratumoral composition of small cell lung carcinoma | Science Advances

Frontiers | Novel Non-Invasive Radiomic Signature on CT Scans Predicts  Response to Platinum-Based Chemotherapy and Is Prognostic of Overall  Survival in Small Cell Lung Cancer
Frontiers | Novel Non-Invasive Radiomic Signature on CT Scans Predicts Response to Platinum-Based Chemotherapy and Is Prognostic of Overall Survival in Small Cell Lung Cancer

JCM | Free Full-Text | Small Cell Lung Cancer from Traditional to  Innovative Therapeutics: Building a Comprehensive Network to Optimize  Clinical and Translational Research
JCM | Free Full-Text | Small Cell Lung Cancer from Traditional to Innovative Therapeutics: Building a Comprehensive Network to Optimize Clinical and Translational Research

Multivalent state transitions shape the intratumoral composition of small  cell lung carcinoma | Science Advances
Multivalent state transitions shape the intratumoral composition of small cell lung carcinoma | Science Advances

SCLC YAP1 Subtype: Potential for Personalized Therapy? - Small Cell Lung  Cancer: Contemporary Concepts
SCLC YAP1 Subtype: Potential for Personalized Therapy? - Small Cell Lung Cancer: Contemporary Concepts

Cancers | Free Full-Text | Pathology and Classification of SCLC
Cancers | Free Full-Text | Pathology and Classification of SCLC

Cancers | Free Full-Text | Emerging Biomarkers and the Changing Landscape  of Small Cell Lung Cancer
Cancers | Free Full-Text | Emerging Biomarkers and the Changing Landscape of Small Cell Lung Cancer

Prototypical oncogene family Myc defines unappreciated distinct lineage  states of small cell lung cancer | Science Advances
Prototypical oncogene family Myc defines unappreciated distinct lineage states of small cell lung cancer | Science Advances